Sonoma Pharmaceuticals, Inc.
SNOA
$5.09
$0.030.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.95% | 5.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.95% | 5.33% | |||
| Cost of Revenue | 14.60% | -2.96% | |||
| Gross Profit | -4.19% | 20.31% | |||
| SG&A Expenses | 10.83% | -5.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.87% | -4.03% | |||
| Operating Income | -66.92% | 36.37% | |||
| Income Before Tax | -135.23% | 42.55% | |||
| Income Tax Expenses | -100.40% | 2,655.56% | |||
| Earnings from Continuing Operations | -59.92% | 16.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -59.92% | 16.38% | |||
| EBIT | -66.92% | 36.37% | |||
| EBITDA | -69.44% | 37.37% | |||
| EPS Basic | -57.18% | 24.10% | |||
| Normalized Basic EPS | -131.18% | 47.85% | |||
| EPS Diluted | -57.18% | 24.10% | |||
| Normalized Diluted EPS | -131.18% | 47.85% | |||
| Average Basic Shares Outstanding | 1.74% | 10.18% | |||
| Average Diluted Shares Outstanding | 1.74% | 10.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||